PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist derived from Melanotan II (MT-II). It has been widely studied for its potential effects on melanocortin receptors (MC1R-MC5R), particularly in research involving sexual function, neurological responses, and vasodilation studies. Unlike PDE5 inhibitors that target blood flow, PT-141 is believed to act on the central nervous system (CNS), influencing dopaminergic pathways related to arousal and motivation.
Nasal delivery is a preferred research method for PT-141 due to its ability to:
Several studies suggest that intranasal administration may provide efficient systemic uptake, making it a viable route for investigating PT-141’s neurological and physiological effects.
PT-141 is believed to work by:
PT-141 is currently being explored in preclinical and clinical research related to:
PT-141 is intended for research purposes only. It is not for human consumption, medical use, or diagnostic applications. All information provided is for scientific and educational research.
LP10 FOR 10% OFF YOUR ORDER